Applied DNA Reports FY’20 Q1 Results
February 6th, 2020
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Category: Press Release
APDN Schedules FY’20 Q1 Financial Results Conference Call
January 30th, 2020
Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT® Platform in Man-Made Cellulosic Fibers and Materials
January 27th, 2020
APDN Subsidiary, LineaRx, Inc., Sign Licensing Agreement with LifeSensors
January 13th, 2020
Applied DNA to Hold Investment Community Meetings During the JP Morgan 38th Annual Healthcare Conference and Present at the Biotech Showcase 2020
January 10th, 2020
Colorcon, Inc. Launches On-Dose Authentication Platform From Applied DNA Sciences
December 23rd, 2019
APDN to Report Year End, FQ4’19 Q4 Financial Results
December 12th, 2019
Applied DNA and Old Port Oil to Conduct First Pilot to Tag CBD Oil
December 11th, 2019
Applied DNA Sciences and Reliance Industries Sign MOU to Incorporate CertainT Forensic Traceability into R|Elan Fabric and Recron GreenGold® Recycled Polyester Fiber and Filament
December 10th, 2019